These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35022375)
1. [Hepatic MALT lymphoma associated with chronic hepatitis B in a patient on trial therapy of Entecavir and H. pylori eradication therapy - case report]. Suemitsu S; Miyaoka Y; Kodama Y; Fujiwara A; Tsukano K; Ogawa S; Yamanouchi S; Tanaka M; Miyake T; Fujishiro H; Kohge N; Onuma H; Ishihara S Nihon Shokakibyo Gakkai Zasshi; 2022; 119(1):79-91. PubMed ID: 35022375 [TBL] [Abstract][Full Text] [Related]
2. [Sustained Complete Remission after Eradication Therapy in A Helicobacter pylori-Negative Cecum Mucosa-Associated Lymphoid Tissue Lymphoma]. Mitsuyama Y; Sata H; Yasumi M; Imakita M; Karasuno T Gan To Kagaku Ryoho; 2020 Oct; 47(10):1513-1515. PubMed ID: 33130753 [TBL] [Abstract][Full Text] [Related]
3. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Montalban C; Santon A; Boixeda D; Bellas C Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887 [TBL] [Abstract][Full Text] [Related]
6. [Endoscopic ultrasound (EUS) in initial assessment and follow-up of patients with MALT lymphoma treated drug therapy]. Pavlović AR; Krstić M; Tomić D; Bjelović M; Jesić R; Suvajdzić N Acta Chir Iugosl; 2005; 52(1):83-9. PubMed ID: 16119319 [TBL] [Abstract][Full Text] [Related]
7. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379 [TBL] [Abstract][Full Text] [Related]
9. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication. Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423 [TBL] [Abstract][Full Text] [Related]
11. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach. Ferreri AJ; Govi S; Ponzoni M Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292 [TBL] [Abstract][Full Text] [Related]
12. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori. Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142 [TBL] [Abstract][Full Text] [Related]
13. Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection. Yoshikane H; Yokoi T; Hidano H; Sakakibara A; Niwa Y; Goto H J Gastroenterol; 1997 Dec; 32(6):812-6. PubMed ID: 9430022 [TBL] [Abstract][Full Text] [Related]
14. [Regression of primary rectal MALT lymphoma after Helicobacter pylori eradication]. Nosaka K; Shono T; Yonemura Y; Iyama K; Sasaki Y; Endo S; Okuno Y; Mitsuya H Rinsho Ketsueki; 2014 Aug; 55(8):948-52. PubMed ID: 25186484 [TBL] [Abstract][Full Text] [Related]
15. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation. Kim YS; Kim JS; Jung HC; Lee CH; Kim CW; Song IS; Kim CY J Gastroenterol; 2002 Jan; 37(1):17-22. PubMed ID: 11824795 [TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission]. Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055 [TBL] [Abstract][Full Text] [Related]
17. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma. Gisbert JP; Calvet X Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927 [TBL] [Abstract][Full Text] [Related]
18. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial. Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma]. Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137 [TBL] [Abstract][Full Text] [Related]
20. The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic Options. Takeuchi Y; Miyahara K; Morito T; Okikawa Y; Kinugasa H; Moritou Y; Higashi R; Kunihiro M; Nakagawa M Intern Med; 2019 Jan; 58(2):207-212. PubMed ID: 30146577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]